{
  "primary": "ATXN3",
  "interaction_type": "indirect",
  "upstream_interactor": "PARK2",
  "mediator_chain": [
    "PARK2"
  ],
  "depth": 2,
  "support_summary": "ATXN3 indirectly regulates the stability of the anti-apoptotic protein B-cell lymphoma 2 (BCL2) by modulating the E3 ligase activity of Parkin (PARK2). ATXN3 deubiquitinates PARK2, which in turn affects PARK2's ability to mono-ubiquitinate and stabilize BCL2.",
  "functions": [
    {
      "function": "BCL2 Protein Stability",
      "arrow": "inhibits",
      "cellular_process": "ATXN3 deubiquitinates the E3 ligase Parkin (PARK2). This deubiquitination of PARK2 by ATXN3 can lead to its degradation. Functional PARK2 normally mono-ubiquitinates the anti-apoptotic and autophagy-inhibitory protein BCL2, which stabilizes BCL2.",
      "effect_description": "By promoting the degradation of PARK2, ATXN3 indirectly decreases the mono-ubiquitination and subsequent stabilization of BCL2, leading to reduced BCL2 levels.",
      "biological_consequence": [
        "ATXN3 deubiquitinates PARK2 → Enhanced PARK2 degradation → Decreased mono-ubiquitination of BCL2 → Reduced BCL2 protein stability → Promotion of autophagy"
      ],
      "specific_effects": [
        "PARK2 directly binds to BCL2 and mediates its mono-ubiquitination.",
        "Mono-ubiquitination of BCL2 by PARK2 increases its steady-state protein level.",
        "ATXN3 counteracts PARK2 self-ubiquitination, and polyQ-expanded ATXN3 promotes the clearance of PARK2 via autophagy.",
        "By stabilizing BCL2, PARK2 enhances the interaction between BCL2 and the autophagy initiator Beclin 1, thereby inhibiting autophagy."
      ],
      "evidence": [
        {
          "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
          "doi": "10.1074/jbc.M110.101469",
          "authors": "Dong Chen, Feng Gao, Bin Li, Hongfeng Wang, Yuxia Xu, Cuiqing Zhu, Guanghui Wang",
          "journal": "Journal of Biological Chemistry",
          "year": 2010,
          "assay": "Co-immunoprecipitation, in vitro ubiquitination assay",
          "species": "human",
          "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2.",
          "pmid": "20889974"
        },
        {
          "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
          "doi": "10.1074/jbc.M111.288449",
          "authors": "Thomas M Durcan, Maria Kontogiannea, Nathalie Bedard, Simon S Wing, Edward A Fon",
          "journal": "Journal of Biological Chemistry",
          "year": 2012,
          "assay": "in vitro ubiquitination assay",
          "species": "human",
          "relevant_quote": "ataxin-3 interferes with the attachment of ubiquitin (Ub) onto parkin in real-time during conjugation but is unable to hydrolyze previously assembled parkin-Ub conjugates.",
          "pmid": "22081612"
        },
        {
          "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
          "doi": "10.1093/hmg/ddq452",
          "authors": "Thomas M Durcan, Maria Kontogiannea, Tinna Thorarinsdottir, Lisa Fallon, Alun J Williams, Aleksandar Djarmati, Teodora Fantaneanu, Henry L Paulson, Edward A Fon",
          "journal": "Human Molecular Genetics",
          "year": 2011,
          "assay": "Western Blot, Co-immunoprecipitation",
          "species": "human, mouse",
          "relevant_quote": "Both wild-type and polyQ-expanded ataxin-3 can deubiquitinate parkin... However, only the expanded version of ataxin-3 promoted the clearance of parkin through the autophagy pathway.",
          "pmid": "20940148"
        }
      ],
      "interaction_effect": "inhibits",
      "direction": "main_to_primary",
      "interaction_direction": "main_to_primary",
      "pmids": [
        "20889974",
        "22081612",
        "20940148"
      ],
      "direct_arrow": "activates",
      "function_effect": "inhibition",
      "arrow_context": {
        "direct_from": "PARK2",
        "direct_arrow": "activates",
        "net_from": "ATXN3",
        "net_arrow": "inhibits",
        "mediator_chain": [
          "PARK2"
        ],
        "is_indirect": true
      },
      "net_arrow": "inhibits",
      "net_effect": "inhibition",
      "direct_effect": "activation"
    }
  ],
  "arrow": "inhibits",
  "direction": "primary_to_main",
  "intent": "regulation of ubiquitination",
  "mechanism": "ATXN3 deubiquitinates the E3 ligase Parkin (PARK2). This deubiquitination of PARK2 by ATXN3 can lead to its degradation. Functional PARK2 normally mono-ubiquitinates the anti-apoptotic and autophagy-inhibitory protein BCL2, which stabilizes BCL2.",
  "effect": "By promoting the degradation of PARK2, ATXN3 indirectly decreases the mono-ubiquitination and subsequent stabilization of BCL2, leading to reduced BCL2 levels.",
  "summary": "ATXN3 inhibits BCL2 to modulate bcl2 protein stability, ultimately affecting promotion of autophagy.",
  "evidence": [
    {
      "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
      "doi": "10.1074/jbc.M110.101469",
      "authors": "Dong Chen, Feng Gao, Bin Li, Hongfeng Wang, Yuxia Xu, Cuiqing Zhu, Guanghui Wang",
      "journal": "Journal of Biological Chemistry",
      "year": 2010,
      "assay": "Co-immunoprecipitation, in vitro ubiquitination assay",
      "species": "human",
      "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2."
    },
    {
      "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
      "doi": "10.1074/jbc.M111.288449",
      "authors": "Thomas M Durcan, Maria Kontogiannea, Nathalie Bedard, Simon S Wing, Edward A Fon",
      "journal": "Journal of Biological Chemistry",
      "year": 2012,
      "assay": "in vitro ubiquitination assay",
      "species": "human",
      "relevant_quote": "ataxin-3 interferes with the attachment of ubiquitin (Ub) onto parkin in real-time during conjugation but is unable to hydrolyze previously assembled parkin-Ub conjugates."
    },
    {
      "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
      "doi": "10.1093/hmg/ddq452",
      "authors": "Thomas M Durcan, Maria Kontogiannea, Tinna Thorarinsdottir, Lisa Fallon, Alun J Williams, Aleksandar Djarmati, Teodora Fantaneanu, Henry L Paulson, Edward A Fon",
      "journal": "Human Molecular Genetics",
      "year": 2011,
      "assay": "Western Blot, Co-immunoprecipitation",
      "species": "human, mouse",
      "relevant_quote": "Both wild-type and polyQ-expanded ataxin-3 can deubiquitinate parkin... However, only the expanded version of ataxin-3 promoted the clearance of parkin through the autophagy pathway."
    }
  ],
  "interaction_effect": "inhibition",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 1
  },
  "_arrow_validated": true,
  "arrow_notation": "PARK2 --inhibits--> BCL2:",
  "protein_a": "BCL2",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-23T07:58:56.172578Z",
  "last_updated": "2025-11-23T07:58:56.172578Z"
}